Deep Bio Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
18
Deep Bio General Information
Description
Developer of deep learning-based medical technology designed to improve reliability and decrease the turnaround time of medical diagnoses. The company uses a convolutional neural network with the input of myriad needle biopsy images to develop the computer-aided detection and diagnosis system for prostate cancer, helping medical professionals to make better-informed decisions that will lead to outcomes for patients.
Contact Information
Website
www.deepbio.co.krCorporate Office
- 609-613, 27, Digital-ro 33-gil
- Guro-gu
- Seoul
- South Korea
Corporate Office
- 609-613, 27, Digital-ro 33-gil
- Guro-gu
- Seoul
- South Korea
Deep Bio Timeline
Deep Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 26-Oct-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 03-Aug-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 02-Mar-2018 | $5.6M | $7.29M | Completed | Generating Revenue | |
| 1. Seed Round | 12-Aug-2017 | $1.69M | $1.69M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Deep Bio Patents
Deep Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025198288-A1 | Method for annotating biological tissue image with lesion type and computing system for performing same | Pending | 20-Mar-2024 | ||
| WO-2025183413-A1 | Method for generating pathological diagnosis report for pathological diagnosis case, and computing system for performing same | Pending | 26-Feb-2024 | ||
| WO-2025164990-A1 | Method for generating representative lesion image of pathological diagnosis case, and computing system for performing same | Pending | 31-Jan-2024 | ||
| WO-2025110600-A1 | Method for generating representative lesion image of biological tissue image, and computing system for performing same | Inactive | 23-Nov-2023 | ||
| WO-2025095396-A1 | Method for training deep learning model for pathological image analysis and computing system performing same | Inactive | 31-Oct-2023 |
Deep Bio Signals
Deep Bio Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Matter (Consulting Services (B2B)) | Accelerator/Incubator | |||
| Gencurix | Corporation | Minority | ||
| Korea AI Startup 100 | Accelerator/Incubator | |||
| Albatross Investment | Venture Capital | Minority | ||
| Daekyo Investment | Corporate Venture Capital | Minority |
Deep Bio FAQs
-
When was Deep Bio founded?
Deep Bio was founded in 2015.
-
Where is Deep Bio headquartered?
Deep Bio is headquartered in Seoul, South Korea.
-
What is the size of Deep Bio?
Deep Bio has 8 total employees.
-
What industry is Deep Bio in?
Deep Bio’s primary industry is Decision/Risk Analysis.
-
Is Deep Bio a private or public company?
Deep Bio is a Private company.
-
What is Deep Bio’s current revenue?
The current revenue for Deep Bio is .
-
How much funding has Deep Bio raised over time?
Deep Bio has raised $8.4M.
-
Who are Deep Bio’s investors?
Matter (Consulting Services (B2B)), Gencurix, Korea AI Startup 100, Albatross Investment, and Daekyo Investment are 5 of 18 investors who have invested in Deep Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process